IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2846 participants.
Also called NCT06451198
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,846 participants
- Sponsor
- Registry
-
NCT06451198
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06451198. Randomized; single masking; primary purpose treatment. Start 2025-05-19 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
- Acronym
- OPTION2
- Condition
- Coronary Artery Disease
- Condition
- Antiplatelet Drugs
- Intervention (Drug)
- Indobufen
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Shanghai Zhongshan Hospital
Record details
- Record id
cardio:ct-nct06451198- Content hash
f54195c6734a7373eb2f1ce8241d21cfff69661da7a022159af3bd68737e69ce